Conference Coverage

High RA biologic drug levels linked with more infections

Publish date: June 29, 2018

 

REPORTING FROM THE EULAR 2018 CONGRESS

SOURCE: Jani M et al. EULAR 2018 Congress, Abstract OP0229.

Pages

Recommended Reading

Functional disability prevails despite rheumatoid arthritis treatment
MDedge Rheumatology
NIH cans study that relied on millions in funding from alcohol companies
MDedge Rheumatology
TNF inhibitor linked to one-third drop in total mortality
MDedge Rheumatology
Serum troponin predicts cardiovascular death in early arthritis
MDedge Rheumatology
Checkpoint inhibitors in autoimmune disease: More flares, better cancer outcomes
MDedge Rheumatology
Severe OA sparks depression, surgery “ameliorates” depression in RA
MDedge Rheumatology
Heart failure confers poor prognosis in rheumatoid arthritis
MDedge Rheumatology
IMAGINE-RA: No need for MRI with treat-to-target strategy
MDedge Rheumatology
Glucocorticosteroid use raises sarcopenia risk in RA
MDedge Rheumatology
EULAR recommendations on steroids: ‘As necessary, but as little as possible’
MDedge Rheumatology

Related Articles